No Data
No Data
NAMSA Acquires the U.S. Medical Device Testing Operations of WuXi AppTec, Solidifying Its Position as the Leader in MedTech Testing and Clinical Research
Express News | JPMorgan Chase & Co's Long Position in H Shares of WuXi AppTec Decreases to 9.46% on Jan 8 From 10.57% - HKEX
WuXi AppTec Raises HK$2.43 Billion via Disposal of WuXi XDC Cayman's Shares
Express News | WuXi AppTec - on November 8, 2024 and January 10, 2025 in Aggregate Disposed of 86,000,000 Shares in WuXi XDC via Two Block Trades
Express News | WuXi AppTec - Aggregate Transaction Amount HK$2.426 Bln
Express News | WuXi AppTec - Disposal of Certain Share Assets